Terms: = Prostate cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras
120 results:
1. Mechanism of Antitumor Effects of Saffron in Human prostate cancer Cells.
Khan M; Hearn K; Parry C; Rasid M; Brim H; Ashktorab H; Kwabi-Addo B
Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201944
[TBL] [Abstract] [Full Text] [Related]
2. The RNA-binding proteins hnRNP H and F regulate splicing of a MYC-dependent hras exon in prostate cancer cells.
Chen X; Yang HT; Zhang B; Phillips JW; Cheng D; Rigo F; Witte ON; Xing Y; Black DL
Proc Natl Acad Sci U S A; 2023 Jul; 120(28):e2220190120. PubMed ID: 37399401
[TBL] [Abstract] [Full Text] [Related]
3. Proteomic analysis of STEAP1 knockdown in human LNCaP prostate cancer cells.
Rocha SM; Santos FM; Socorro S; Passarinha LA; Maia CJ
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119522. PubMed ID: 37315586
[TBL] [Abstract] [Full Text] [Related]
4. Caffeic acid phenethyl ester suppresses EGFR/FAK/Akt signaling, migration, and tumor growth of prostate cancer cells.
Tseng JC; Wang BJ; Wang YP; Kuo YY; Chen JK; Hour TC; Kuo LK; Hsiao PJ; Yeh CC; Kao CL; Shih LJ; Chuu CP
Phytomedicine; 2023 Jul; 116():154860. PubMed ID: 37201366
[TBL] [Abstract] [Full Text] [Related]
5. Membrane tension-mediated stiff and soft tumor subtypes closely associated with prognosis for prostate cancer patients.
Feng D; Wang J; Shi X; Li D; Wei W; Han P
Eur J Med Res; 2023 May; 28(1):172. PubMed ID: 37179366
[TBL] [Abstract] [Full Text] [Related]
6. Network Toxicology Prediction and Molecular Docking-based Strategy to Explore the Potential Toxicity Mechanism of Metformin Chlorination Byproducts in Drinking Water.
Zhang GH; Liu H; Liu MH; Liu YC; Wang JQ; Wang Y; Wang X; Xiang Z; Liu W
Comb Chem High Throughput Screen; 2024; 27(1):101-117. PubMed ID: 37170985
[TBL] [Abstract] [Full Text] [Related]
7. Post-transcriptional modification of m
Li Y; Zhu S; Chen Y; Ma Q; Kan D; Yu W; Zhang B; Chen X; Wei W; Shao Y; Wang K; Zhang M; Deng S; Niu Y; Shang Z
Cell Death Dis; 2023 Apr; 14(4):289. PubMed ID: 37095108
[TBL] [Abstract] [Full Text] [Related]
8. Whole-exome sequencing analysis of NSCLC reveals the pathogenic missense variants from cancer-associated genes.
Kumar S U; Balasundaram A; Cathryn R H; Varghese RP; R S; R G; Younes S; Zayed H; Doss C GP
Comput Biol Med; 2022 Sep; 148():105701. PubMed ID: 35753820
[TBL] [Abstract] [Full Text] [Related]
9. MiR-622 acts as a tumor suppressor to induce cell apoptosis and inhibit metastasis in human prostate cancer.
Targhazeh N; Yousefi B; Asghari S; Mohammadnejhad R; Mansouri P; Valizadeh A
Andrologia; 2021 Oct; 53(9):e14174. PubMed ID: 34231241
[TBL] [Abstract] [Full Text] [Related]
10. A new horizon for the old antibacterial drug clofoctol.
Bailly C; Vergoten G
Drug Discov Today; 2021 May; 26(5):1302-1310. PubMed ID: 33581321
[TBL] [Abstract] [Full Text] [Related]
11. 1α,25-Dihydroxyvitamin D
Ben-Eltriki M; Deb S; Guns EST
J Steroid Biochem Mol Biol; 2021 May; 209():105828. PubMed ID: 33493594
[TBL] [Abstract] [Full Text] [Related]
12. A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer.
Cario CL; Chen E; Leong L; Emami NC; Lopez K; Tenggara I; Simko JP; Friedlander TW; Li PS; Paris PL; Carroll PR; Witte JS
BMC Cancer; 2020 Aug; 20(1):820. PubMed ID: 32859160
[TBL] [Abstract] [Full Text] [Related]
13. PIN-like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations.
Kaur HB; Salles DC; Paulk A; Epstein JI; Eshleman JR; Lotan TL
Histopathology; 2021 Jan; 78(2):327-333. PubMed ID: 32740981
[TBL] [Abstract] [Full Text] [Related]
14. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway.
Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X
J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180
[TBL] [Abstract] [Full Text] [Related]
15. RAL GTPases: Biology and Potential as Therapeutic Targets in cancer.
Yan C; Theodorescu D
Pharmacol Rev; 2018 Jan; 70(1):1-11. PubMed ID: 29196555
[TBL] [Abstract] [Full Text] [Related]
16. PTEN loss and activation of k-ras and β-catenin cooperate to accelerate prostate tumourigenesis.
Jefferies MT; Cox AC; Shorning BY; Meniel V; Griffiths D; Kynaston HG; Smalley MJ; Clarke AR
J Pathol; 2017 Dec; 243(4):442-456. PubMed ID: 29134654
[TBL] [Abstract] [Full Text] [Related]
17. Oncogenic k-ras upregulates ITGA6 expression via FOSL1 to induce anoikis resistance and synergizes with αV-Class integrins to promote EMT.
Zhang K; Myllymäki SM; Gao P; Devarajan R; Kytölä V; Nykter M; Wei GH; Manninen A
Oncogene; 2017 Oct; 36(41):5681-5694. PubMed ID: 28604746
[TBL] [Abstract] [Full Text] [Related]
18. Suppression of PKC causes oncogenic stress for triggering apoptosis in cancer cells.
Ganapathy S; Peng B; Shen L; Yu T; Lafontant J; Li P; Xiong R; Makriyannis A; Chen C
Oncotarget; 2017 May; 8(19):30992-31002. PubMed ID: 28415683
[TBL] [Abstract] [Full Text] [Related]
19. Synergistic Impact of d-δ-Tocotrienol and Geranylgeraniol on the Growth and HMG CoA Reductase of Human DU145 prostate Carcinoma Cells.
Yeganehjoo H; DeBose-Boyd R; McFarlin BK; Mo H
Nutr Cancer; 2017; 69(4):682-691. PubMed ID: 28362175
[TBL] [Abstract] [Full Text] [Related]
20. miR-494-3p is a novel tumor driver of lung carcinogenesis.
Faversani A; Amatori S; Augello C; Colombo F; Porretti L; Fanelli M; Ferrero S; Palleschi A; Pelicci PG; Belloni E; Ercoli G; Degrassi A; Baccarin M; Altieri DC; Vaira V; Bosari S
Oncotarget; 2017 Jan; 8(5):7231-7247. PubMed ID: 27980227
[TBL] [Abstract] [Full Text] [Related]
[Next]
